Brief report
Norepinephrine infusions in congestive heart failure

https://doi.org/10.1016/0002-9149(85)91146-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (15)

There are more references available in the full text version of this article.

Cited by (22)

  • Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α<inf>1</inf>-adrenoreceptor signal transduction

    2008, American Heart Journal
    Citation Excerpt :

    This increased BP response was evident despite sustained reductions in preinfusion BP, suggesting a previously undescribed pharmacologic consequence of carvedilol in subjects with HF: the potential up-regulation of impaired vascular α1-AR signal transduction in human HF. Goldsmith et al24 first reported evidence for desensitization of vascular α1-ARs in subjects with HF. In this study, supraphysiologic doses of norepinephrine failed to elicit a BP or HR response, suggesting some defect or impairment of the α1-AR signaling pathway in patients with HF.

  • Changes in myocardial and vascular receptors in heart failure

    1993, Journal of the American College of Cardiology
  • Catecholamines in Critical Care

    1987, Critical Care Clinics
View all citing articles on Scopus
View full text